FrancophonIA/ELRC3.0 huggingface dataset:
English: Inhibitors of CYP 1A2: because CYP1A2 is involved in duloxetine metabolism, concomitant use of duloxetine with potent inhibitors of CYP1A2 is likely to result in higher concentrations of duloxetine.
Slovenian: Zaviralci CYP1A2: ker je CYP1A2 vpleten v presnovo duloksetina, je verjetno, da bo sočasna uporaba duloksetina z močnimi zaviralci CYP1A2 povzročila višje koncentracije duloksetina.
English: The efficacy of duloxetine as a treatment for diabetic neuropathic pain was established in 2 randomised, 12-week, double-blind, placebo-controlled, fixed dose studies in adults (22 to 88 years) having diabetic neuropathic pain for at least 6 months.
Slovenian: Učinkovitost duloksetina kot zdravila za bolečino pri diabetični nevropatiji so ugotavljali v 2 randomiziranih 12-tedenskih dvojno slepih s placebom kontroliranih študijah z določenim odmerkom pri odraslih (starih od 22 do 88 let), ki so imeli bolečino diabetične nevropatije vsaj 6 mesecev.
English: The effect of DULOXETINE BOEHRINGER INGELHEIM may be noticeable in many patients with diabetic neuropathic pain within 1 week of treatment.
Slovenian: Učinek zdravila DULOKSETIN BOEHRINGER INGELHEIM je pri mnogih bolnikih z bolečino diabetične nevropatije opazen v 1 tednu zdravljenja.
English: Duloxetine is well absorbed after oral administration with a Cmax occurring 6 hours post dose.
Slovenian: Duloksetin se po peroralnem jemanju dobro absorbira s pojavom Cmax 6 ur po odmerjanju.
English: No clinically significant differences were observed for QT, PR, QRS, or QTcB measurements between duloxetinetreated and placebo-treated patients.
Slovenian: Pri meritvah QT, PR, QRS ali QTcB niso opažali klinično pomembnih razlik med bolniki, zdravljenimi z duloksetinom, in bolniki, ki so prejemali placebo.
English: • need to pass more urine than normal, need to pass urine during the night, difficulty or inability to pass urine or having an urine flow decreased
Slovenian: • bolj pogosto odvajanje urina, nočno odvajanje urina, težave ali nezmožnost odvajanja urina ali slabši curek urina
English: In particular the combination with selective reversible MAOIs is not recommended.
Slovenian: Še posebej odsvetujemo kombinacijo duloksetina s selektivnimi reverzibilnimi MAOI.
English: If your doctor thinks that you no longer need DULOXETINE BOEHRINGER INGELHEIM he or she will ask you to reduce your dose over at least 2 weeks before stopping treatment altogether.
Slovenian: Če bo vaš zdravnik menil, da zdravila DULOKSETIN BOEHRINGER INGELHEIM ne potrebujete več, vam bo naročil/naročila, da pred prenehanjem zdravljenja 2 tedna postopoma znižujte svoj odmerek.
English: Despite this, your doctor may prescribe DULOXETINE BOEHRINGER INGELHEIM for patients under 18 because he/she decides that this is in their best interests.
Slovenian: Temu navkljub lahko vaš zdravnik predpiše zdravilo DULOKSETIN BOEHRINGER INGELHEIM tudi bolnikom, mlajšim od 18 let, če se odloči, da je to v njihovo najboljšo korist.
English: • grinding of teeth, feeling hot/cold, thirst, throat tightness, nose bleeds
Slovenian: • škrtanje z zobmi, dehidracija, občutek vročine/mraza, žeja, napeto grlo, krvavitve iz nosu
English: If you stop taking DULOXETINE BOEHRINGER INGELHEIM DO NOT stop taking your capsules without the advice of your doctor even if you feel better.
Slovenian: Če ste prenehali jemati zdravilo DULOKSETIN BOEHRINGER INGELHEIM Ne prenehajte jemati svojih kapsul, če vam ni tako svetoval vaš zdravnik, tudi če se bolje počutite.
English: feeling of being drunk, fever, sweating or rigid muscles)
Slovenian: vročino, znojenje ali toge mišice)
English: • mania (over activity, racing thoughts and decrease need for sleep)
Slovenian: • manija (prevelika aktivnost, bežeče misli in zmanjšana potreba po spanju), agresivnost in jeza
English: ANNEX II A. MANUFACTURING AUTHORISATION HOLDER(S) RESPONSIBLE FOR BATCH RELEASE
Slovenian: DODATEK II A. IMETNIK(I) DOVOLJENJA ZA IZDELAVO ZDRAVILA, ODGOVOREN (ODGOVORNI) ZA SPROŠČANJE SERIJE
English: If you forget to take DULOXETINE BOEHRINGER INGELHEIM If you miss a dose, take it as soon as you remember.
Slovenian: Če ste pozabili vzeti zdravilo DULOKSETIN BOEHRINGER INGELHEIM Če pozabite vzeti odmerek, ga zaužijte, kakor hitro se spomnite.
English: Mania Hallucinations anger4
Slovenian: Manija Halucinacije Agresija in jeza4
English: Also, the long-term safety effects concerning growth, maturation, and cognitive and behavioural development of DULOXETINE BOEHRINGER INGELHEIM in this age group have not yet been demonstrated.
Slovenian: Dolgoročni učinki zdravila DULOKSETIN BOEHRINGER INGELHEIM na varnost glede rasti, dozorevanja in kognitivnega ter vedenjskega razvoja v tej starostni skupini tudi še niso bili ugotovljeni.
English: Tell your doctor if you
Slovenian: Obvestite svojega zdravnika, če:
English: Renal impairment: end stage renal disease (ESRD) patients receiving dialysis had 2-fold higher duloxetine Cmax and AUC values compared with healthy subjects.
Slovenian: Okvarjeno delovanje ledvic: bolniki s končno odpovedjo ledvic v programu dialize so imeli 2-krat višje vrednosti Cmax in AUC duloksetina v primerjavi z zdravimi osebami.
English: When stopping treatment with DULOXETINE BOEHRINGER INGELHEIM the dose should be gradually reduced over a period of at least one to two weeks in order to reduce the risk of withdrawal reactions (see sections 4.4 and 4.8).
Slovenian: Ob prenehanju zdravljenja z zdravilom DULOKSETIN BOEHRINGER INGELHEIM je treba odmerek zdravila v obdobju najmanj enega do dveh tednov postopoma zmanjševati, da zmanjšamo tveganje za pojav odtegnitvenih reakcij (glejte poglavji 4.4 in 4.8).
English: • tasting things differently than usual, disturbance in attention, stiffness, spasms and involuntary movements of the muscles, muscle twitching, abnormal manner of walking
Slovenian: • spremenjeno okušanje stvari, motnja pozornosti, okornost, krči in nehoteni gibi mišic, mišično trzanje, nenormalen način hoje
English: Blood pressure increase Peripheral coldness Orthostatic hypotension2 Syncope2
Slovenian: Hladni periferni deli Ortostatska hipotenzija2 Sinkopa2
English: Monoamine Oxidase Inhibitors (MAOIs): You should not take DULOXETINE BOEHRINGER INGELHEIM if you are taking, or have recently taken within the last 14 days, another antidepressant medicine called a monoamine oxidase inhibitor (MAOI).
Slovenian: Zaviralci monoaminooksidaze (MAOI): zdravila DULOKSETIN BOEHRINGER INGELHEIM ne smete jemati, če jemljete ali ste v zadnjih 14 dneh vzeli drugo antidepresivno zdravilo, imenovano zaviralec monoaminooksidaze (MAOI).
English: You should inform your doctor if any of the symptoms listed above develop or worsen when patients under 18 are taking DULOXETINE BOEHRINGER INGELHEIM.
Slovenian: Svojega zdravnika obvestite, če se kateri od zgoraj naštetih simptomov pri bolniku, mlajšemu od 18 let, ki jemlje zdravilo DULOKSETIN BOEHRINGER INGELHEIM, pojavi ali poslabša.
English: The initiation of treatment with DULOXETINE BOEHRINGER INGELHEIM is contraindicated in patients with uncontrolled hypertension that could expose patients to a potential risk of hypertensive crisis (see sections 4.4 and 4.8).
Slovenian: Uvedba zdravljenja z zdravilom DULOKSETIN BOEHRINGER INGELHEIM je kontraindicirana pri bolnikih z nenadzorovano hipertenzijo, ki lahko izpostavi bolnike možnemu tveganju za hipertenzivno krizo (glejte poglavje 4.4 in 4.8).
English: The most commonly observed adverse reactions in patients with diabetic neuropathic pain treated with DULOXETINE BOEHRINGER INGELHEIM were: nausea; headache, dry mouth and somnolence and dizziness.
Slovenian: Neželeni učinki, katere so pri bolnikih z bolečino diabetične nevropatije, zdravljenih z zdravilom DULOKSETIN BOEHRINGER INGELHEIM, najpogosteje opažali, so bili: slabost, glavobol, suha usta in zaspanost ter omotica.
English: Feeling abnormal Feeling cold Thirst
Slovenian: Občutek mraza Žeja
English: The main ingredient of DULOXETINE BOEHRINGER INGELHEIM, duloxetine, is used in other medicines for other conditions:
Slovenian: Poglavitno sestavino zdravila DULOKSETIN BOEHRINGER INGELHEIM, duloksetin, uporabljamo tudi v drugih zdravilih za zdravljenje drugih bolezni:
English: Musculoskeletal and connective tissue disorders Musculoskeletal pain
Slovenian: Bolezni mišično-skeletnega sistema in vezivnega tkiva Mišičnoskeletna bolečina
English: Night sweats Urticaria Dermatitis contact Cold sweat Photosensitivity reactions Increased tendency to bruise
Slovenian: Nočno znojenje Urtikarija Kontaktni dermatitis Hladen znoj Fotosenzitivno
English: • hallucinations, suicidal thoughts, behaviour aggression and anger
Slovenian: • halucinacije, samomorilne misli, vedenje
English: Throat tightness Epistaxis
Slovenian: Stisnjeno grlo Epistaksa
English: Caution is advised in patients taking anticoagulants and/or medicinal products known to affect platelet function, and in patients with known bleeding tendencies.
Slovenian: Pri bolnikih, ki jemljejo zdravila proti strjevanju krvi in/ali druga zdravila, za katera je znano, da vplivajo na delovanje trombocitov, ter pri bolnikih z znano nagnjenostjo h krvavitvam je potrebna previdnost.
English: Consequently, caution is advised when DULOXETINE BOEHRINGER INGELHEIM is taken in combination with other centrally acting medicinal products and substances including alcohol and sedative medicinal products (e.g. benzodiazepines, morphinomimetics, antipsychotics, phenobarbital, sedative antihistamines).
Slovenian: Zato je pri jemanju zdravila DULOKSETIN BOEHRINGER INGELHEIM v kombinaciji z drugimi osrednje delujočimi zdravili in snovmi, ki vključujejo alkohol in pomirjevala (denimo benzodiazepini, morfinomimetiki, antipsihotiki, fenobarbital, sedirajoči antihistaminiki), potrebna previdnost.
English: In clinical trials adverse events seen on abrupt treatment discontinuation occurred in approximately 45% of patients treated with DULOXETINE BOEHRINGER INGELHEIM and 23% of patients taking placebo.
Slovenian: V kliničnih preskušanjih so se neželeni učinki ob nenadni prekinitvi zdravljenja pojavili pri približno 45 % bolnikov, ki so jemali zdravilo DULOKSETIN BOEHRINGER INGELHEIM in pri 23 % bolnikov, ki so dobivali placebo.
English: Reproductive System and Breast Disorders Erectile dysfunction
Slovenian: Motnje reprodukcije in dojk Erektilna disfunkcija
English: Menopausal symptoms
Slovenian: Menopavzalni simptomi
English: Taking DULOXETINE BOEHRINGER INGELHEIM with food and drink DULOXETINE BOEHRINGER INGELHEIM may be taken with or without food.
Slovenian: Jemanje zdravila DULOKSETIN BOEHRINGER INGELHEIM skupaj s hrano in pijačo Zdravilo DULOKSETIN BOEHRINGER INGELHEIM lahko vzamete s hrano ali brez nje.
English: DULOXETINE BOEHRINGER INGELHEIM may cause a sensation of restlessness or an inability to sit or stand still.
Slovenian: Zdravilo DULOKSETIN BOEHRINGER INGELHEIM lahko povzroči občutek nemira ali nezmožnosti sedenja ali stanja pri miru.
English: Cases of liver injury, including severe elevations of liver enzymes (>10 times upper limit of normal), hepatitis and jaundice have been reported with duloxetine (see section 4.8).
Slovenian: Ob zdravljenju z duloksetinom so poročali o primerih okvare jeter, vključno z zvišanjem vrednosti jetrnih encimov (> 10 kratna zgornja meja normalnih vrednosti), hepatitisom in zlatenico (glejte poglavje 4.8).
English: Use in children and adolescents under 18 years of age DULOXETINE BOEHRINGER INGELHEIM should normally not be used for children and adolescents under 18 years.
Slovenian: Uporaba pri otrocih in mladostnikih, mlajših od 18 let Zdravila DULOKSETIN BOEHRINGER INGELHEIM pri otrocih in mladostnikih, mlajših od 18 let, običajno ne uporabljamo.
English: Like all medicines, DULOXETINE BOEHRINGER INGELHEIM can cause side effects, although not everybody gets them.
Slovenian: Kot vsa zdravila ima lahko tudi zdravilo DULOKSETIN BOEHRINGER INGELHEIM neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
English: DULOXETINE BOEHRINGER INGELHEIM should not be used in the treatment of children and adolescents under the age of 18 years.
Slovenian: Zdravila DULOKSETIN BOEHRINGER INGELHEIM pri zdravljenju otrok in mladostnikov, mlajših od 18 let, ne smemo uporabljati.
English: DULOXETINE BOEHRINGER INGELHEIM is used in adults to treat a condition called diabetic neuropathic pain (often described as burning, stabbing, stinging, shooting or aching or like an electric shock.
Slovenian: Zdravilo DULOKSETIN BOEHRINGER INGELHEIM se uporablja za lajšanje bolečine pri diabetični nevropatiji pri odraslih (Pogosto jo opisujejo kot pekočo, zbadajočo, pikajočo, prebadajočo ali podobno stresanju elektrike.
English: • tiredness, trouble sleeping, anxiety, feeling agitated or having abnormal dreams
Slovenian: • utrujenost, motnja spanja, tesnoba, občutek razdraženosti ali nenavadne sanje
English: Hyponatremia may be due to a syndrome of inappropriate anti-diuretic hormone secretion (SIADH).
Slovenian: Hiponatriemija je lahko posledica sindroma neustreznega izločanja antidiuretičnega hormona (syndrome of inappropriate anti-diuretic hormone secretion, SIADH).
English: If a decision to initiate antidepressant pharmacological therapy is taken, the gradual discontinuation of DULOXETINE BOEHRINGER INGELHEIM is recommended (see Section 4.2).
Slovenian: V primeru, da se zdravnik odloči za farmakološko zdravljenje z antidepresivi, svetujemo postopno ukinjanje zdravila DULOKSETIN BOEHRINGER INGELHEIM (glejte poglavje 4.2).
English: Effects of other medicinal products on duloxetine Antacids and H2 antagonists: co-administration of duloxetine with aluminium- and magnesiumcontaining antacids or duloxetine with famotidine had no significant effect on the rate or extent of duloxetine absorption after administration of a 40 mg oral dose.
Slovenian: Antacidi in antagonisti H2: sočasno dajanje duloksetina z antacidi, vsebujočimi aluminij in magnezij, ali duloksetina s famotidinom ni imelo pomembnega učinka na hitrost ali obseg absorpcije duloksetina po dajanju 40 mg peroralnega odmerka.
English: Monoamine Oxidase Inhibitors (MAOIs): due to the risk of serotonin syndrome, DULOXETINE BOEHRINGER INGELHEIM should not be used in combination with nonselective irreversible monoamine oxidase inhibitors (MAOIs), or within at least 14 days of discontinuing treatment with an
Slovenian: Zaviralci monoaminooksidaze (MAOI): zaradi nevarnosti za serotoninski sindrom zdravila DULOKSETIN BOEHRINGER INGELHEIM ne smemo uporabljati v kombinaciji z neselektivnimi ireverzibilnimi zaviralci monoaminooksidaze (MAOI) ali v 14 dneh po prenehanju zdravljenja z MAOI.
English: If while on DULOXETINE BOEHRINGER INGELHEIM therapy, the patient develops agitation or depressive symptoms, specialised medical advice should be sought, as depression is a serious medical condition.
Slovenian: Če bolnik med zdravljenjem z zdravilom DULOKSETIN BOEHRINGER INGELHEIM postane agitiran ali razvije simptome depresije, se je treba posvetovati s specialistom, depresija je namreč resno bolezensko stanje.
English: DULOXETINE BOEHRINGER INGELHEIM should be used with caution in patients with a history of mania or a diagnosis of bipolar disorder, and/or seizures.
Slovenian: Zdravilo DULOKSETIN BOEHRINGER INGELHEIM je treba pri bolnikih z manijo v anamnezi ali z diagnozo bipolarne motnje in/ali epileptičnimi napadi uporabljati previdno.
English: Do not stop taking DULOXETINE BOEHRINGER INGELHEIM without talking to your doctor.
Slovenian: Ne prenehajte jemati zdravila DULOKSETIN BOEHRINGER INGELHEIM, ne da bi se posvetovali s svojim zdravnikom.
English: DULOXETINE BOEHRINGER INGELHEIM should not be used in combination with fluvoxamine, ciprofloxacin or enoxacine (i.e. potent CYP1A2 inhibitors) since the combination results in elevated plasma concentrations of duloxetine (see section 4.5).
Slovenian: Zdravila DULOKSETIN BOEHRINGER INGELHEIM ne smemo uporabljati v kombinaciji s fluvoksaminom, ciprofloksacinom ali enoksacinom (tj. močnimi zaviralci CYP1A2), saj kombinacija povzroči povišane plazemske koncentracije duloksetina (glejte poglavje 4.5).
English: • menopausal symptoms
Slovenian: • menopavzalni simptomi
English: • become pregnant, or you are trying to become pregnant, while you are taking DULOXETINE BOEHRINGER INGELHEIM.
Slovenian: • zanosite ali poskušate zanositi, medtem ko jemljete zdravilo DULOKSETIN BOEHRINGER INGELHEIM.
English: • dizziness, tingling feelings like pins and needles, sleep disturbances (vivid dreams, nightmares,
Slovenian: • omotica, ščemenje (občutek zbadanja z iglami), motnje spanja (žive sanje, nočne more,
English: Medicines that increase the level of serotonin: triptans, tramadol, tryptophan, SSRIs (such as paroxetine and fluoxetine), tricyclics (such as clomipramine, amitriptyline), pethidine, St John's Wort and venlafaxine.
Slovenian: Zdravila, ki zvišajo nivo serotonina: triptani, tramadol, triptofan, SSRI (kot sta paroksetin in fluoksetin), triciklični antidepresivi (kot sta klomipramin, amitriptilin), petidin, šentjanževka in venlafaksin.
English: General Disorders and Administration Site Conditions Fatigue
Slovenian: Splošne težave in spremembe na mestu aplikacije Utrujenost
English: Your doctor should decide whether you can take DULOXETINE BOEHRINGER INGELHEIM with other medicines.
Slovenian: Vaš zdravnik se mora odločiti, ali lahko jemljete zdravilo DULOKSETIN BOEHRINGER INGELHEIM z drugimi zdravili.
English: You must wait at least 14 days after you have stopped taking an MAOI before you can take DULOXETINE BOEHRINGER INGELHEIM.
Slovenian: Po prenehanju jemanja MAOI morate počakati vsaj 14 dni, preden lahko vzamete zdravilo DULOKSETIN BOEHRINGER INGELHEIM.
English: Orgasm abnormal
Slovenian: Anksioznost Nenormalen orgazem
English: What DULOXETINE BOEHRINGER INGELHEIM is and what it is used for Before you take DULOXETINE BOEHRINGER INGELHEIM How to take DULOXETINE BOEHRINGER INGELHEIM Possible side effects
Slovenian: Kaj je zdravilo DULOKSETIN BOEHRINGER INGELHEIM in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo DULOKSETIN BOEHRINGER INGELHEIM Kako jemati zdravilo DULOKSETIN BOEHRINGER INGELHEIM Možni neželeni učinki
English: Serotonin syndrome: in rare cases, serotonin syndrome has been reported in patients using SSRIs (e.g. paroxetine, fluoxetine) concomitantly with serotonergic medicinal products.
Slovenian: Serotoninski sindrom: pri bolnikih, ki so SSRI (denimo paroksetin, fluoksetin) uporabljali sočasno s serotonergičnimi zdravili, so v redkih primerih poročali o serotoninskem sindromu.
English: Do not start or stop taking any medicines, including those bought without a prescription and herbal remedies, before checking with your doctor.
Slovenian: vključno s tistimi, ki ste jih kupili brez recepta, in pripravkov rastlinskega izvora, ne da bi se pred tem posvetovali s svojim zdravnikom.
English: As the safety of duloxetine in infants is not known, the use of DULOXETINE BOEHRINGER INGELHEIM while breast-feeding is not recommended.
Slovenian: Ker varnost uporabe duloksetina pri dojenčkih ni znana, odsvetujemo uporabo zdravila DULOKSETIN BOEHRINGER INGELHEIM med dojenjem.
English: For patients not experiencing somnolence, clinical response was observed in 47% of patients receiving duloxetine and 27% patients on placebo.
Slovenian: V skupini bolnikov, ki niso poročali o zaspanosti, so klinični odziv opažali pri 47 % bolnikov, ki so prejemali duloksetin, in pri 27 % bolnikov, ki so prejemali placebo.
English: Do not use DULOXETINE BOEHRINGER INGELHEIM after the expiry date which is stated on the carton.
Slovenian: Zdravila DULOKSETIN BOEHRINGER INGELHEIM ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli.
English: Mydriasis has been reported in association with duloxetine, therefore, caution should be used when prescribing DULOXETINE BOEHRINGER INGELHEIM to patients with increased intraocular pressure, or those at risk of acute narrow-angle glaucoma.
Slovenian: V povezavi z duloksetinom so poročali o midriazi, zato je pri predpisovanju zdravila DULOKSETIN BOEHRINGER INGELHEIM bolnikom s povišanim intraokularnim tlakom ali s tveganjem za akutni glavkom z zaprtim zakotjem potrebna previdnost.
English: To help you remember to take DULOXETINE BOEHRINGER INGELHEIM, you may find it easier to take it at the same times every day.
Slovenian: Morda se boste lažje spomnili vzeti zdravilo DULOKSETIN BOEHRINGER INGELHEIM, če ga boste jemali vsak dan ob istih urah.
English: Laryngitis
Slovenian: Laringitis
English: Important information about some of the ingredients of DULOXETINE BOEHRINGER INGELHEIM
Slovenian: Pomembne informacije o nekaterih sestavinah zdravila DULOKSETIN BOEHRINGER INGELHEIM
English: PHARMACEUTICAL FORM AND CONTENTS 7 hard gastro-resistant capsules, 28 hard gastro-resistant capsules 98 hard gastro-resistant capsules
Slovenian: FARMACEVTSKA OBLIKA IN VSEBINA 7 trdih gastrorezistentnih kapsul 28 trdih gastrorezistentnih kapsul 98 trdih gastrorezistentnih kapsul
English: Capsule content: hypromellose, Hypromellose Acetate Succinate, sucrose, sugar spheres, talc, titanium dioxide (E171), triethyl citrate.
Slovenian: Vsebina kapsule: hipromeloza, hipromeloza acetat sukcinat, saharoza, sladkorne kroglice, smukec, titanov dioksid (E171), trietilcitrat.
English: WHAT DULOXETINE BOEHRINGER INGELHEIM IS AND WHAT IT IS USED FOR
Slovenian: KAJ JE ZDRAVILO DULOKSETIN BOEHRINGER INGELHEIM IN ZA KAJ GA UPORABLJAMO
English: The PSUR cycle of Duloxetine Boehringer Ingelheim will correspond to the one attributed to the cross-referred product, Ariclaim, until otherwise specified.
Slovenian: Ciklus PSUR-jev zdravila Duloksetin Boehringer Ingelheim bo ustrezal referenčnemu zdravilu Ariclaim, razen če ne bo drugače navedeno.
English: Talk with your doctor about how long you should keep taking DULOXETINE BOEHRINGER INGELHEIM.
Slovenian: S svojim zdravnikom se pogovorite o tem, kako dolgo boste jemali zdravilo DULOKSETIN BOEHRINGER INGELHEIM.
English: Nervous System Disorders Headache
Slovenian: Bolezni živčevja Glavobol
English: Stomatitis Breath odour Haematochezia
Slovenian: Stomatitis Slab zadah Hematohezija
English: DULOXETINE BOEHRINGER INGELHEIM may be associated with sedation and dizziness.
Slovenian: Zdravilo DULOKSETIN BOEHRINGER INGELHEIM je lahko povezano s sedacijo in omotico.
English: Hyponatremia
Slovenian: Hiponatremija
English: DULOXETINE BOEHRINGER INGELHEIM should not be used in patients with severe renal impairment (creatinine clearance <30 ml/min; see section 4.3).
Slovenian: Zdravila DULOKSETIN BOEHRINGER INGELHEIM ne smemo uporabljati pri bolnikih s hudo okvarjenim delovanjem ledvic (očistek kreatinina < 30 ml/min; glejte poglavje 4.3).
English: • syndrome of inadequate secretion of anti-diuretic hormone (SIADH)
Slovenian: • sindom nezadostnenega izločanja antidiuretičnega hormona (SIADH - syndrome of inadequate secretion of anti-diuretic hormone)
English: DULOXETINE BOEHRINGER INGELHEIM 30 mg is available in packs of 7, 28 and 98 capsules.
Slovenian: Zdravilo DULOKSETIN BOEHRINGER INGELHEIM 30 mg je na voljo v pakiranju po 7, 28 in 98 kapsul.
English: If you take more DULOXETINE BOEHRINGER INGELHEIM than you should Call your doctor or pharmacist immediately if you take more than the amount of DULOXETINE BOEHRINGER INGELHEIM prescribed by your doctor.
Slovenian: Če ste vzeli večji odmerek zdravila DULOKSETIN BOEHRINGER INGELHEIM, kot bi smeli Če vzamete večjo količino zdravila DULOKSETIN BOEHRINGER INGELHEIM, kot vam je predpisal vaš zdravnik, nemudoma pokličite svojega zdravnika ali farmacevta.
English: A MANUFACTURING AUTHORISATION HOLDER(S) RESPONSIBLE FOR BATCH RELEASE
Slovenian: A. IMETNIK(I) DOVOLJENJA ZA IZDELAVO ZDRAVILA, ODGOVOREN (ODGOVORNI) ZA SPROŠČANJE SERIJE
English: Uncommon side effects (these can affect from 1 to 10 users in 1,000 patients treated)
Slovenian: Občasni neželeni učinki (se lahko pojavijo pri 1 do 10 bolnikov od 1.000 zdravljenih bolnikov)
English: Edible White Ink: titanium dioxide (E171), propylene glycol, shellac, povidone.
Slovenian: Užitno belo črnilo: titanov dioksid (E171), propilenglikol, šelak, povidon.